HealthCare Global Enterprises Limited Share Price

Equities

HCG

INE075I01017

Healthcare Facilities & Services

Delayed NSE India S.E. 10:24:58 25/06/2024 BST 5-day change 1st Jan Change
378.2 INR -0.80% Intraday chart for HealthCare Global Enterprises Limited -1.84% +3.49%

Financials

Sales 2024 19.08B 229M 18.01B Sales 2025 * 21.79B 261M 20.56B Capitalization 53.11B 637M 50.13B
Net income 2024 481M 5.77M 454M Net income 2025 * 842M 10.09M 795M EV / Sales 2024 2.47 x
Net Debt 2024 * 5.61B 67.23M 5.29B Net Debt 2025 * 8.38B 100M 7.91B EV / Sales 2025 * 2.82 x
P/E ratio 2024
98.5 x
P/E ratio 2025 *
58.9 x
Employees 6,136
Yield 2024 *
-
Yield 2025 *
-
Free-Float 26.92%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : HealthCare Global Enterprises Limited, Q4 2024 Earnings Call, May 30, 2024
HealthCare Global Enterprises Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Temasek May Bid for CVC's 60% Stake in Healthcare Global CI
HealthCare Global Enterprises Limited acquired remaining 49.5% stake in Hcg Eko Oncology LLP from Eko-diagnostic Pvt Ltd for INR 200 million. CI
EQT, TPG and KKR Reportedly Eye Majority Stake in HCG CI
Transcript : HealthCare Global Enterprises Limited, Q3 2024 Earnings Call, Feb 09, 2024
HealthCare Global Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : HealthCare Global Enterprises Limited, Q2 2024 Earnings Call, Nov 10, 2023
HealthCare Global Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
HealthCare Global Enterprises Limited cancelled the acquisition of Radiation therapy centre of Radiant Hospital Services Private Limited from Radiant Hospitality Services Private Limited. CI
HealthCare Global Acquires Cancer Hospital in Indore, India MT
HealthCare Global Enterprises Limited completed the acquisition of Radiation Business from Amrish Oncology Services Private Limited. CI
HealthCare Global Enterprises Limited completed the acquisition of Oncology Business from SRJ Health Care Private Limited. CI
CVC Capital Mulls Selling Stake in HealthCare Global Enterprises CI
CVC Capital mulls selling stake in Indian healthcare firm - Bloomberg News RE
More news

Latest transcript on HealthCare Global Enterprises Limited

1 day-0.80%
1 week-1.84%
Current month+4.85%
1 month+5.03%
3 months+9.13%
6 months+2.00%
Current year+3.49%
More quotes
1 week
370.25
Extreme 370.25
394.00
1 month
330.65
Extreme 330.65
395.95
Current year
314.00
Extreme 314
401.00
1 year
313.00
Extreme 313
401.00
3 years
212.40
Extreme 212.4
401.00
5 years
62.05
Extreme 62.05
401.00
10 years
62.05
Extreme 62.05
401.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 31/01/21
Founder - 11/03/98
Director of Finance/CFO - 20/08/23
Members of the board TitleAgeSince
Director/Board Member 63 24/05/23
Founder - 11/03/98
Director/Board Member 56 27/07/20
More insiders
Date Price Change Volume
25/06/24 378.2 -0.80% 55 431
24/06/24 381.3 0.00% 199,694
21/06/24 381.3 -1.60% 111,145
20/06/24 387.5 +1.28% 135,183
19/06/24 382.6 -0.71% 151,358

Delayed Quote NSE India S.E., June 25, 2024 at 10:24 am

More quotes
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. Under the HCG brand, the Company operates cancer care network in India in terms of the total number of private cancer treatment centers. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. Under the Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
381.3 INR
Average target price
411.1 INR
Spread / Average Target
+7.82%
Consensus